Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 72971 SAN FRANCISCO, CA
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$363,551
+$231,632 QoQ
Shares Held
24,935
+138.7% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ENTA ranks #206 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ENTA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $363,551 24,935
2026-03-31 $131,919 10,445
2025-12-31 $484,389 30,716
2025-09-30 $186,718 15,599
2025-06-30 $113,988 15,078
2025-03-31 $78,377 14,199
2024-12-31 $91,314 15,881
2024-09-30 $96,999 9,363
2024-06-30 $116,313 8,968
2024-03-31 $434,910 24,909
2023-12-31 $58,134 6,178
2023-09-30 $55,602 4,978
2023-06-30 $523,936 24,483
2023-03-31 $564,217 13,952
2022-12-31 $37,959 816
2022-09-30 $96,527 1,861
2022-06-30 $98,320 2,080
2022-03-31 $1,187,565 16,684
2021-12-31 $1,670,808 22,343
2021-09-30 $881,008 15,508
2021-06-30 $909,465 20,665
2021-03-31 $206,994 4,197
2020-12-31 $1,778,471 42,244
2020-09-30 $1,857,522 40,575
2020-06-30 $2,083,362 41,493
2020-03-31 $1,766,670 34,351